Videos

Gil Kliman, MD, managing director of InterWest and OIS co-chair, is joined by Stephen Slade, MD, of Slade & Baker Vision, to lead a spirited…

Moderator and OIS Co-Chair Bill Link asks what’s on everyone’s mind during the Masters of the Industry panel at OIS@ASCRS.

Jonathan Norris, managing director, Silicon Valley Bank, compares Medtech financing to biopharma start-ups. The data on deals are interesting, showing distinct trends for both sectors.…

Andrew Gitkin, head, West Coast biotechnology investment banking, Piper Jaffray, reviews the impact the Trump presidency is having on the public markets. He also hits…

Chuck Hess, vice president and general manager, US Surgical, Bausch & Lomb, says retina will play a significant role in the company’s growth going forward.…

Brent Wilde, president, Minnesota Eye Consultants, shares the biggest challenges facing ophthalmology practices. He also discusses how eye care practices are handling consolidation in comparison…

Andy Doraiswamy, former COO of Oculeve, explains how he came to play a key role in the development of Oculeve, the dry eye company acquired…

Andrew Gitkin, head of West Coast biotechnology investment banking – Piper Jaffray, says ophthalmology start-ups stand to benefit from a “renaissance of information” that’s giving…

Ali Behbahani, MD, partner at NEA, outlines the “unique aspects” that make ophthalmology an interesting area for VCs to invest capital. He also explains what…

Richard Lindstrom, MD, founder of Minnesota Eye Consultants, discusses his group’s partnership with Waud Capital to create a new national ophthalmology practice leader. Dr. Lindstrom…

David Alpern, founding partner of Varsity Healthcare Partners, says the ophthalmology industry is due to run up against several financial and demographic challenges going forward.…